We’re raising our Eli Lilly price target — what a difference a quarter makes
Eli Lilly shares jumped Thursday after the drugmaker posted a strong third quarter, driven by sales of its popular GLP-1...
HEALTH & FITNESS
Breast cancer drug stock Olema could more than double from here, analysts say
Wall Street is optimistic that Olema Pharmaceutical could be developing the next major breakthrough breast cancer treatment.Earlier this month, the...
Eli Lilly (LLY) earnings Q3 2025
Eli Lilly on Thursday reported third-quarter earnings and revenue that topped estimates and hiked its full-year outlook, as the company...
Merck (MRK) earnings Q3 2025
Merck on Thursday reported third-quarter earnings and revenue that topped estimates as it saw strong demand for its cancer immunotherapy...
This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is ‘growing substantially’
It's been a stellar few months for shares of San Francisco-based biotech company Rigel Pharmaceuticals, which has approved treatments for...
‘Trump effect’ raises hopes for cannabis rally
Oils containing CBD (Cannabidiol).Geoffroy Van Der Hasselt | AFP | Getty ImagesCannabis stocks could be poised for a rally after...
What’s next for the weight loss drug market: pills, rivals, insurance
A combination image shows an injection pen of Zepbound, Eli Lilly's weight loss drug, and boxes of Wegovy, made by...
Pfizer files second lawsuit against Novo Nordisk, Metsera
A Pfizer logo is displayed at a research facility in the La Jolla neighborhood of San Diego, California, U.S., Sept....
Trump Republicans health insurance
U.S. President Donald Trump gestures as he speaks during an event to announce a deal with Eli Lilly and Novo...
Metsera calls Novo Nordisk’s new bid superior to Pfizer offer
The logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy is seen...
Pfizer (PFE) earnings Q3 2025
Pfizer CEO Albert Bourla speaks during a press conference after a visit to oversee the production of the Pfizer-BioNtech Covid-19...
Pfizer, Novo Nordisk escalate Metsera bidding war
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to...
Eli Lilly’s amylin obesity drug shows up to 20% weight loss in study
Eli Lilly Biotechnology Center is shown in San Diego, California, March 1, 2023.Mike Blake | ReutersEli Lilly on Thursday said...
Omada Health to start prescribing GLP-1s, other obesity medications
The Omada Health logo is displayed on a smartphone screen.Sopa Images | Lightrocket | Getty ImagesVirtual care company Omada Health...
Trump, Eli Lilly, Novo Nordisk unveil deals to cut obesity drug prices
U.S. President Donald Trump attends an event to make an announcement from the Oval Office at the White House in...
Trump deals with Lilly, Novo Nordisk could broaden obesity drug access
US President Donald Trump makes an announcement in the Oval Office of the White House in Washington, DC on Nov....
Trump strikes deal with Eli Lilly, Novo Nordisk
Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025. Shelby Knowles | Bloomberg | Getty ImagesPresident...
‘You need to know,’ warns Talkspace CEO
Talkspace has grown to be one of the largest online therapy platforms in the U.S., covering an estimated market of...
Trump reaches deal with AstraZeneca to lower U.S. drug prices
Trump announced the agreement with AstraZeneca on Friday, after striking a similar deal with Pfizer late last month. Source link
Amgen, other drugmakers launch DTC programs
The Amgen headquarters in Thousand Oaks, California.Eric Thayer | Bloomberg | Getty ImagesA version of this article first appeared in...
